{"filings":[{"id":93288,"accession_number":"0001493152-26-021301","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SuRo Capital NAV surges 76% to $14.24; Board approves externalization with Magnetar","event_type":"other_material","confidence":"high","bullets":["Net assets $361.6M ($14.24/share) vs $8.09 at Dec 31, 2025; $6.15/share gain in Q1.","Board approved transition to externally managed structure via Neostellar Advisors LLC (joint venture with Magnetar), subject to stockholder vote.","Magnetar affiliate to invest $20M in SuRo; current management (Klein, Green) to remain.","Top holdings: WHOOP ($150.8M), OpenAI fund ($59.3M), VAST Data ($32.8M), Blink Health ($21.0M), CoreWeave ($15.9M).","Q1 net realized gain $0.9M; unrealized appreciation $158.7M; net investment loss $4.0M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93287,"accession_number":"0001493152-26-015439","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2026-04-07T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"SuRo Capital proposes externalization with Magnetar; Q1 NAV est. $14.00-$14.50","event_type":"other_material","confidence":"high","bullets":["Q1 2026 estimated NAV per share $14.00-$14.50; liquid assets ~$46M as of March 31, 2026.","Board proposes externalization via joint venture with Magnetar (AUM ~$17.8B); stockholder vote required.","Externalization expected to yield annual cost savings of 0.77% of avg total assets; no incentive fee on existing portfolio.","Magnetar to invest $20M in SuRo Capital; management (Klein, Green) to continue under new adviser.","If approved, name to change to Neostellar Capital Corp.; conditional restricted shares and cash bonuses for executives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104779,"accession_number":"0001493152-26-009475","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SuRo Capital Q4 NAV $8.09, down from $9.23; expects $5-$6.50 per share accretion in 2026","event_type":"earnings","confidence":"high","bullets":["NAV per share $8.09 at Dec 31 (down from $9.23 Sep 30), but up from $6.68 a year ago.","Full-year 2025 net increase in net assets $48.8M ($2.01 per share) vs. net decrease of $38.1M in 2024.","Expects portfolio financings early 2026 to add ~$5.00-$6.50 per share to NAV (not yet reflected).","Declared $0.25 per share dividends in July and Dec 2025 (total $0.50 per share for the year).","Extended note repurchase program for up to $40M of 6% Notes due 2026; $39.2M repurchased to date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104778,"accession_number":"0001493152-26-001901","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"SuRo Capital Q4 portfolio update: exits yield $12.2M proceeds; commits $20M to TensorWave AI","event_type":"other_material","confidence":"high","bullets":["Q4 exits included CW Opportunity 2 LP ($9.0M proceeds, $6.7M gain), Forge Global ($3.1M, $1.1M gain), and a $1.0M loss on Rebric.","After year-end, funded $5M of $20M commitment to Magnetar/TensorWave SPV; remaining $15M subject to conditions.","Portfolio holds 35 companies (32 private, 3 public); no NAV range provided pending year-end confirmations.","Total dividends declared in 2025 were $0.50 per share, paid in two $0.25 cash dividends on July 31 and Dec 5.","Full Q4 and FY2025 results expected week of March 9, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121054,"accession_number":"0001493152-25-020747","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SuRo Capital Q3 2025 NAV $9.23/share; declares $0.25 dividend","event_type":"earnings","confidence":"high","bullets":["Net asset value $9.23 per share at Sep 30 2025, up from $8.93 (div-adjusted) at Jun 30 2025 and $6.48 year ago.","Board declares $0.25 per share cash dividend payable Dec 5, 2025 to holders of record Nov 21, 2025.","Portfolio fair value $252.2M; top 5 (CoreWeave, Whoop, OpenAI, Blink Health, Learneo) are 51.5% of total.","Q3 net realized gain $5.2M ($0.21/share) from CoreWeave and GrabAGun sales; net investment loss $3.5M.","Extended note repurchase program by $40M and share repurchase program with $25M remaining."],"consensus_eps_estimate":null,"consensus_eps_actual":2.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121053,"accession_number":"0001493152-25-017485","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2025-10-09T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"SuRo Capital prelim Q3 NAV est $9.00-$9.50; invests $5M in HYPE digital token","event_type":"earnings","confidence":"high","bullets":["NAV per share estimated $9.00-$9.50 at Sep 30, 2025, vs $9.18 at Jun 30, 2025 and $6.73 at Sep 30, 2024.","Invested $5M in HL Digital Assets (HYPE token) and $0.3M follow-on in Liquid Death convertible note.","Realized $3.7M gain on partial sale of CW Opportunity 2 LP (CoreWeave) for $7.2M proceeds.","Sold 1,230,984 shares via ATM for $10.8M gross; ~$88M remaining capacity.","Paid $0.25 per share cash dividend on Jul 31, 2025; 25.1M shares outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":2.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137687,"accession_number":"0001493152-25-011649","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SuRo Capital Reports Q2 2025 NAV of $9.18 Per Share, Up from $6.66, Initiates $0.25 Dividend","event_type":"earnings","confidence":"high","bullets":["Net asset value per share rose to $9.18 as of June 30, 2025, from $6.66 at March 31, 2025 – a 38% increase.","Board declared an initial cash dividend of $0.25 per share, driven by successful monetizations of public securities.","CoreWeave’s IPO and OpenAI’s $40B raise at $300B valuation were key drivers of portfolio appreciation.","Deployed $5M into Plaid via an SPV; exited CoreWeave and ServiceTitan for combined realized gains of $21.2M.","Net increase in net assets from operations totaled $62.3 million for Q2 2025, versus a loss of $10.7M year ago."],"consensus_eps_estimate":null,"consensus_eps_actual":2.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.9,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137686,"accession_number":"0001641172-25-018505","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2025-07-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SuRo Capital files investor presentation; no specific financial results disclosed","event_type":"other_material","confidence":"low","bullets":["Filed Form 8-K on July 9, 2025 referencing an investor presentation.","Presentation dated July 9, 2025 posted on company website; no earnings or guidance included.","No material operational or financial updates provided in the filing or exhibit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137685,"accession_number":"0001641172-25-018085","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2025-07-08T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"SuRo Capital Q2 NAV per share estimated $9.00-$9.50, up >35% QoQ; $0.25 dividend declared","event_type":"earnings","confidence":"high","bullets":["NAV per share estimated $9.00–$9.50 at June 30, 2025, up from $6.66 at March 31, 2025.","Q2 new investment of $5.0M in Plaid Inc. (Class A shares) via SPV with 7% origination fee.","Exited CoreWeave and ServiceTitan holdings, realizing combined net proceeds of $41.2M and gains of $21.2M.","Declared dividend of $0.25/share payable July 31, 2025 to holders of record July 21, 2025.","Liquid assets ~$52.4M; portfolio of 36 companies (33 private, 3 public)."],"consensus_eps_estimate":null,"consensus_eps_actual":2.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155066,"accession_number":"0001641172-25-015799","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"SuRo Capital appoints Richard Szuch as independent director, effective July 1, 2025","event_type":"leadership","confidence":"high","bullets":["Board increased size from 5 to 6 directors; vacancy created and filled by Richard Szuch.","Szuch appointed to Nominating & Corporate Governance, Valuation, and Compensation committees.","Determined independent under Nasdaq rules and not an 'interested person' under Investment Company Act.","Term expires at 2027 annual meeting; compensation per existing director compensation plan.","No arrangements, understandings, or reportable transactions involving Szuch."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155065,"accession_number":"0001104659-25-054873","cik":1509470,"company_name":"SURO CAPITAL CORP.","ticker":"SSSS","form_type":"8-K","filed_at":"2025-05-30T23:59:59+00:00","items":["1.01","5.02","5.07","9.01"],"status":"ready","headline":"SuRo Capital extends CEO/CFO employment to Dec 2029; stockholders elect directors, approve plans","event_type":"leadership","confidence":"high","bullets":["CEO Mark Klein employment extended to Dec 31, 2029; bonus target set at 100% of base salary.","CFO Allison Green employment also extended to Dec 31, 2029; bonus target at 125% of base salary.","Stockholders reelected Ronald Lott and Marc Mazur to board at May 28 annual meeting.","Advisory say-on-pay approved (7,089,990 for); frequency set at 1 year (7,060,239 for).","Equity incentive plan amendment and ratification of CBIZ CPAs as auditor approved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}